Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1

American Journal of Pathology

Volumn 179, Issue 3, 2011, Pages 1504-1512

  Yang, Yan ^a,b   Liu, Ying ^a   Yao, Xiaohong ^c   Ping, Yifang ^c   Jiang, Tao ^d   Liu, Qin ^c   Xu, Senlin ^c   Huang, Jian ^c   Mou, Haiwei ^e   Gong, Wanghua ^f   Chen, Keqiang ^a   Bian, Xiuwu ^c   Ming Wang, Ji ^a,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OCEAN UNIVERSITY OF CHINA   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^f SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; LIPOCORTIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CELL PROLIFERATION; COLONY FORMATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOADSORPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TUMOR NECROSIS; TUMOR XENOGRAFT;

ANIMALS; ANNEXIN A1; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTAXIS; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NECROSIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECEPTORS, FORMYL PEPTIDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 80052854250     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.05.059     Document Type: Article

References (25)

1. Y. Zhou, X. Bian, Y. Le, W. Gong, J. Hu, X. Zhang, L. Wang, P. Iribarren, R. Salcedo, O.M.Z. Howard, W. Farrar, and J.M. Wang Formylpeptide receptor FPR and the rapid growth of malignant human gliomas J Natl Cancer Inst 97 2005 823 835 (Pubitemid 40909125)
2. J. Huang, K. Chen, W. Gong, N.M. Dunlop, and J.M. Wang G-protein coupled chemoattractant receptors and cancer Front Biosci 13 2008 3352 3363 (Pubitemid 351594687)
3. R.D. Ye, F. Boulay, J.M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C.N. Serhan, and P.M. Murphy International Union of Basic and Clinical Pharmacology LXXIII Nomenclature for the formyl peptide receptor (FPR) family Pharmacol Rev 61 2009 119 161
4. Y. Le, P.M. Murphy, and J.M. Wang Formyl-peptide receptors revisited Trends Immunol 23 2002 541 548 (Pubitemid 35223553)
5. J. Huang, K. Chen, W. Gong, Y. Zhou, Y. Le, X. Bian, and J.M. Wang Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression Cancer Lett 267 2008 254 261
6. M.J. Rabiet, E. Huet, and F. Boulay Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR Eur J Immunol 35 2005 2486 2495 (Pubitemid 41179770)
7. B.A. Babbin, W.Y. Lee, C.A. Parkos, L.M. Winfree, A. Akyildiz, M. Perretti, and A. Nusrat Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors J Biol Chem 281 2006 19588 19599 (Pubitemid 44035462)
8. R. Sun, P. Iribarren, N. Zhang, Y. Zhou, W. Gong, E.H. Cho, S. Lockett, O. Chertov, F. Bednar, T.J. Rogers, J.J. Oppenheim, and J.M. Wang Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor J Immunol 173 2004 428 436 (Pubitemid 38797369)
9. X.H. Yao, Y.F. Ping, J.H. Chen, C.P. Xu, D.L. Chen, R. Zhang, J.M. Wang, and X.W. Bian Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR J Pathol 215 2008 369 376
10. J. Huang, K. Chen, J. Huang, W. Gong, N.M. Dunlop, O.M.Z. Howard, X. Bian, Y. Gao, and J.M. Wang Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation Carcinogenesis 30 2009 348 355
11. Y. Le, P. Iribarren, Y. Zhou, W. Gong, J. Hu, X. Zhang, and J.M. Wang Silencing the formylpeptide receptor FPR by short-interfering RNA Mol Pharmocol 64 2004 1022 1028 (Pubitemid 39319474)
12. J. Huang, J. Hu, X. Bian, K. Chen, W. Gong, N.M. Dunlop, O.M.Z. Howard, and J.M. Wang Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells Cancer Res 67 2007 5906 5913 (Pubitemid 46985026)
13. S.J. Getting, R.J. Flower, and M. Perretti Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1 Br J Pharmacol 120 1997 1075 1082 (Pubitemid 27122647)
14. R.J. Flower, and N.J. Rothwell Lipocortin-1: cellular mechanisms and clinical relevance Trends Pharmacol Sci 15 1994 71 76 (Pubitemid 24086941)
15. A. Walther, K. Riehemann, and V. Gerke A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR Mol Cell 5 2000 831 840
16. M. Perretti, S.J. Getting, E. Solito, P.M. Murphy, and J.L. Gao Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of Anx A1 and its mimetics Am J Pathol 158 2001 1969 1973 (Pubitemid 32545181)
17. W. Wu, X. Tang, W. Hu, R. Lotan, W.K. Hong, and L. Mao Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry Clin Exp Metastasis 19 2002 319 326 (Pubitemid 34606757)
18. X.F. Bai, X. Ni, P. Zhao, S.M. Liu, H.X. Wang, B. Guo, L.P. Zhou, F. Liu, J.S. Zhang, K. Wang, Y.Q. Xie, Y.F. Shao, and X.H. Zhao Overexpression of Anx A1 in pancreatic cancer and its clinical significance World J Gastroenterol 10 2004 1466 1470 (Pubitemid 39206812)
19. F. Rondepierre, B. Bouchon, J. Papon, M. Bonnet-Duquennoy, R. Kintossou, N. Moins, J. Maublant, J.C. Madelmont, M. D'Incan, and F. Degoul Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination Biochim Biophys Acta 1794 2009 61 69
20. M. Yi, and J.E. Schnitzer Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice Proc Natl Acad Sci USA 106 2009 17886 17891
21. L.A. Liotta, and E.C. Kohn The microenvironment of the tumour-host interface Nature 411 2001 375 379
22. Y. De, Q. Chen, A.P. Schmidt, G.M. Anderson, J.M. Wang, J. Wooters, J.J. Oppenheim, and O. Chertov LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J Exp Med 192 2000 1069 1074
23. S. Tokumaru, K. Sayama, Y. Shirakata, H. Komatsuzawa, K. Ouhara, Y. Hanakawa, Y. Yahata, X. Dai, M. Tohyama, H. Nagai, L. Yang, S. Higashiyama, A. Yoshimura, M. Sugai, and K. Hashimoto Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37 J Immunol 175 2005 4662 4668 (Pubitemid 41362007)
24. S.B. Coffelt, F.C. Marini, K. Watson, K.J. Zwezdaryk, J.L. Dembinski, H.L. LaMarca, S.L. Tomchuck, K. Honer zu Bentrup, E.S. Danka, S.L. Henkle, and A.B. Scandurro The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells Proc Natl Acad Sci USA 106 2009 3806 3811
25. J.A. Joyce, and J.W. Pollard Microenvironmental regulation of metastasis Nat Rev Cancer 9 2009 239 252